Molecular characterization of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Kazakhstan

Japanese Journal of Infectious Diseases

Volumn 64, Issue 3, 2011, Pages 253-255

  Kozhamkulov, Ulan ^a   Akhmetova, Ainur ^a   Rakhimova, Saule ^a   Belova, Elena ^b   Alenova, Arike ^b   Bismilda, Venera ^b   Chingissova, Lyailya ^b   Ismailov, Shahimurat ^b   Ramanculov, Erlan ^a   Momynaliev, Kuvat ^a  

^a NATIONAL CENTER FOR BIOTECHNOLOGY   (Kazakhstan)

^b National Center for Tuberculosis Problems   (Kazakhstan)

Author keywords

[No Author keywords available]

Indexed keywords

ENOYL ACYL CARRIER PROTEIN REDUCTASE (NADH); ETHAMBUTOL; ISONIAZID; KATG PROTEIN; OXIDOREDUCTASE; PROTEIN AHPC; PROTEIN OXYR; REGULATOR PROTEIN; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; SPACER DNA; STREPTOMYCIN; UNCLASSIFIED DRUG;

AHPC GENE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CODON; CONTROLLED STUDY; GENE MUTATION; INHA GENE; KATG GENE; KAZAKHSTAN; MUTATIONAL ANALYSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OXYR GENE; PROMOTER REGION; RPOB GENE;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA MUTATIONAL ANALYSIS; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; ISONIAZID; KAZAKHSTAN; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 79958031478     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Ministry of Health Republic of Kazakhstan. Statistic TB Review (Editor Sh. Ismailov). National TB Center, Almaty, 2009 (in Russian).
2. Ministry of Health Republic of Kazakhstan. Statistic TB Review (Editor T. Abildaev). National TB Center, Almaty, 2010 (in Russian).
3. Hillemann, D., Kubica, T., Agzamova, R., et al. (2005): Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int. J. Tuberc. Lung Dis., 9, 1161-1167.
4. World Health Organization (1998): Laboratory Services in Tuberculosis Control. Part III: Culture. Global Tuberculosis Programme (WHO/TB/98.258). World Health Organization, Geneva, Switzerland.
5. World Health Organization (2003): Guidelines for Surveillance of Drug Resistance in Tuberculosis. 2nd ed. Global Tuberculosis Programme (WHO/CDS/TB/2003.320). World Health Organization, Geneva, Switzerland.
6. Philip, S. (2005): Multilocus Variable Number Tandem Repeat Genotyping of Mycobacterium tuberculosis. Technical Guide. INSERM U629, Institut de Biologie/Institut Pasteur de Lille, France.
7. Afanasev, M.-V, Ikryannikova, L.-N, Ilina, E.-N., et al. (2007): Molecular characteristics of rifampicin- and isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J. Antimicrob. Chem., 59, 1057-1064.
8. Coll, P., Aragon L.-M., Alcaide, F., et al. (2005): Molecular analysis of isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates recovered from Barcelona. Microb. Drug Resist., 11, 107-114.
9. Baker, L.V., Brown, T.J., Maxwell O., et al. (2005): Molecular analysis of isoniazid-resistantMycobacterium tuberculosis isolates from England and Wales reveals the phylogenetic significance of the ahpC -46A polymorphism. Antimicrob. Agents Chem., 49, 1455-1464.
10. Telenti, A., Honore, N., Bernasconi, C., et al. (1997): Genotyping assessment of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a blind study at reference laboratory level. J. Clin. Microbiol., 35, 719-723.